Peptide Clinical Safety: Adverse Events, Unknowns and Reporting
Read peptide adverse-event data with the right denominators and limits. Understand safety signals, AEMS reporting, clinical trials and FDA MedWatch pathways.
Read articleBlog · Page 3
Perspectives on peptide science, research, and the evidence behind it.
Latest articles
Showing 19–26 of 26 articles
Cagrilintide: Published Trials and Regulatory Status
Read cagrilintide and CagriSema trial results, distinguish standalone and combination evidence, and check dated U.S. regulatory status and ongoing studies.
Read article
Peptide Hormones vs Small-Molecule Medicines
Compare peptide and small-molecule medicines through delivery, targets, safety and evidence. Understand why neither class is universally better.
Read article
How to Verify Peptide Claims Shared on Social Media
Fact-check peptide claims from social media using the original paper, the exact outcome, the source and regulatory records. A five-step method.
Read article
Why a Study Abstract Can Be Misleading
Learn how to read a study abstract without overinterpreting it. Compare endpoints, methods and limitations using an annotated real peptide-research example.
Read article
How to Check Whether a Clinical Trial Was Published
Find a clinical trial’s published results using its NCT number, registry results, PubMed and publisher records, with a worked STEP 1 example.
Read article
What a Scientific Correction or Retraction Means
Understand corrections, expressions of concern and retractions. Check publisher notices, Crossmark and PubMed before relying on a scientific claim.
Read article
Peptide Research Evidence Checklist for Readers
Use a printable peptide research checklist to verify sources, endpoints, uncertainty, harms and approval claims. Includes a worked trial example.
Read article